---
$id: https://graph.org.ai/products/commodity/51141574
$type: Product
source: UNSPSC
code: "51141574"
title: "Progabide"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Progabide

**UNSPSC Code**: 51141574
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant, antidepressive agent, antiparkinson agent, and gaba agonist with the molecular formula C17H16ClFN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 38C836J57Z, chemically known as butyramide, 4-(alpha-(p-chlorophenyl)-5-fluoro-2-hydroxybenzylideneamino)- but generally known as progabide, which bears US NIH Compound Identifier 5361323. European Medicines Agency schedules Progabide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10075MIG. World Health Organization schedules progabide in its Anatomical Therapeutic Chemical (ATC) Classification. PROGABIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule progabide under HS 29242995 and SITC 51479. As of Q4 2014, PROGABIDE remains the US FDA Preferred Term for this commodity. SMILES: CLC1CCC(C(=C2\C=C(F)C=CC2=O)\NCCCC(=O)N)CC1.

